Confronting antifungal resistance, tolerance, and persistence: Advances in drug target discovery and delivery systems
- 16 July 2023
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 200, 115007
Abstract
No abstract availableKeywords
This publication has 152 references indexed in Scilit:
- The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal InfectionsAntimicrobial Agents and Chemotherapy, 2012
- Amphotericin primarily kills yeast by simply binding ergosterolProceedings of the National Academy of Sciences, 2012
- In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and MoldsAntimicrobial Agents and Chemotherapy, 2011
- Regulation of Efflux Pump Expression and Drug Resistance by the Transcription Factors Mrr1, Upc2, and Cap1 in Candida albicansAntimicrobial Agents and Chemotherapy, 2011
- Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: Influences of fatty acidsColloids and Surfaces B: Biointerfaces, 2011
- Mutational Analysis of Flucytosine Resistance in Candida glabrataAntimicrobial Agents and Chemotherapy, 2010
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2010
- Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin AAntimicrobial Agents and Chemotherapy, 2009
- Systematic Genetic Analysis of Virulence in the Human Fungal Pathogen Cryptococcus neoformansCell, 2008
- Chitosan, the Deacetylated Form of Chitin, Is Necessary for Cell Wall Integrity in Cryptococcus neoformansEukaryotic Cell, 2007